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The lack of specific treat-
ment planning tools limits
the spread of Intraoperative
Electron Radiation Therapy.
An innovative simulation
and planning tool is pre-
sented. Applicator posi-
tioning, isodose curves, and
dose volume histograms
can be estimated for previ-
ously segmented regions to
treat/protect. Evaluation by
three radiation oncologists
on 15 patients showed high
parameter agreement in nine
cases, demonstrating the
possibilities in cases
involving different anatom-
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mce.hggm.esPurpose: Intraoperative electron beam radiation therapy (IOERT) involves a modified strategy
of conventional radiation therapy and surgery. The lack of specific planning tools limits the
spread of this technique. The purpose of the present study is to describe a new simulation
and planning tool and its initial evaluation by clinical users.
Methods and Materials: The tool works on a preoperative computed tomography scan. A physi
cian contours regions to be treated and protected and simulates applicator positioning, calcu
lating isodoses and the corresponding doseevolume histograms depending on the selected
electron energy. Three radiation oncologists evaluated data from 15 IOERT patients, including
different tumor locations. Segmentation masks, applicator positions, and treatment parameters
were compared.
Results: High parameter agreement was found in the following cases: three breast and three
rectal cancer, retroperitoneal sarcoma, and rectal and ovary monotopic recurrences. All radiation
oncologists performed similar segmentations of tumors and high risk areas. The average appli
cator position difference was 1.2  0.95 cm. The remaining cancer sites showed higher devia 
tions because of differences in the criteria for segmenting high risk areas (one rectal, one
pancreas) and different surgical access simulated (two rectal, one Ewing sarcoma).
Conclusions: The results show that this new tool can be used to simulate IOERT cases involving
different anatomic locations, and that preplanning has to be carried out with specialized surgical
input.
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identifying the importance of
specialized surgical input in
the preplanning process.Introduction
Intraoperative radiation therapy (IOERT) refers to the delivery of
radiation to the postresected tumor bed, or to an unresected tumor,
during the surgical procedure (1). The technique enables the precise
application of a high radiation dose to the target area while mini
mizing exposure to surroundings tissues, which are displaced or
shielded during the procedure (2). However, running an IOERT
program involves several aspects from the institutional point of view
because it is necessary to organize structural and human resources.
Conventional or mobile linear accelerators are used for IOERT. A
multidisciplinary group of surgeons, anesthetists, medical physi
cists, radiation oncologists (ROs), and technical and nursing staff
have to be involved. The twomain actors are the surgeon and theRO,
and both must provide their knowledge and experience in the
decision making process, identifying the high risk areas and mobi
lizing noninvolved dose sensitive organs. Finally, the ROwill define
the treatment volume, prescribe the dose, and report the results (3).
Although treatment planning is a necessary step in external
radiotherapy, the corresponding procedure has not been available
in IOERT up to now. There are several reasons for this: most
organs at risk are displaced or protected during surgery, the
electron beam presents a very high dose gradient (4), and the
treatment volume is directly visualized by the surgeon and the RO.
Although all these circumstances support IOERT practice, this
does not mean that treatment planning is not desirable. In current
clinical practice, all necessary parameters such as applicator
diameter, bevel angle, position, and electron beam energy are
decided by the RO in real time, with high dependence on accu
mulated expertise (5). This also means that postsurgical follow up
cannot include objective variables such as volume coverage for
target and healthy tissue; consequently, local tumor control and
toxicity are not completely documented.
Although there are several treatment planning tools for bra
chytherapy that work on imaging studies (6), no such develop
ments have been available for IOERT. The first proposal on IOERT
simulation was reported by our own research group (7). The
underlying idea was that simulating the IOERT procedure was
feasible by displaying the virtual position of the applicator super
imposed on the patient’s computed tomography (CT) or magnetic
resonance image. With this approach, the treatment parameters
could be predefined depending on the patient’s anatomy, and the
RO could improve the preoperative planning for the procedure.
This initial proposal was later implemented and improved,
becoming the so called Radiance IOERT simulation and planning
tool (GMVAerospace and Defence, Madrid, Spain). Development
of the system has brought together industrial and academic part
ners: Hospital General Universitario Gregorio Maran˜o´n (HGUGM)
and Consorcio Hospitalario Provincial de Castello´n (HPC). The
simulation and planning process is performed in several steps:
segmentation, applicator positioning using CT images, and
parameter selection (applicator diameter, bevel angle, and electron
beam energy) by optimizing the doseevolume histograms on the
regions. The results of the process can be stored in a single file,
allowing for comparison of different procedures. The main features2and advantages of this approach will be presented in this article,
together with an initial evaluation in clinical cases by three ROs.
Methods and Materials
The system allows IOERT simulation and planning, giving the
user support in the different steps of this workflow. A CT image of
the patient including the tumor location is acquired before IOERT.
The user navigates through the axial, sagittal, and coronal
sections, and also with a three dimensional (3D) volume rendering
(Fig. 1). The rendering engine takes advantage of the graphics
process unit capabilities, providing real time updates when the
rendering parameters are modified. The steps followed to simulate
and plan the IOERT are described below. The RO can interact with
the surgeon to define several aspects of the procedure.
Image segmentation
The RO performs the segmentation on axial, coronal, or sagittal
sections, and these contours can be combined into a single 3D
region of interest. This contouring process is slightly different
from the one performed in external radiotherapy. First, the tumor is
not the target volume, because it might be resected during surgery,
but it must be segmented for correct placement of the IOERT
applicator. At the same time, only the organs at risk that could not
be displaced and manipulated during the surgical process should
be taken into account. Finally, the planning treatment volume
(PTV) is the region surrounding the tumor (residual or tumor bed)
that is considered to have a high risk for relapse, or the tumor itself
for unresectable cases. Tumor location, the patient’s clinical
history, and radiologic reports are factors to consider when con
touring the PTV. Regions that are not expected to be present during
surgery can be hidden from the two dimensional and 3D display
(virtual surgery effect). The result will be the definition of a series
of regions of interest (Fig. 2), with their corresponding labels,
which will be the basis for the following steps.
Surgical frame definition
With this optional tool, the RO defines the expected anatomic
regional access (e.g., lateral, anterior, perineal) and dimensions of
the surgical incision. This feature improves the representation of
the procedure in the 3D volume rendering and at the same time
limits the possible movements of the IOERT applicator in the next
steps (navigation effect), resembling the physical geometric
limitations of the real procedure (Fig. 3).
Definition of applicator parameters
With the organs at risk, target areas, and surgical procedure
defined, the user can now decide on the applicator best adapted for
the desired treatment and also the proper position and orientation
related to the patient’s anatomy and limited by the surgical frame.
Fig. 1. Computed tomography of the abdomen demonstrating three dimensional rendering capabilities in the Radiance system with
different color and opacity tables.The user can modify the applicator parameters (diameter, bevel
angle, position, and orientation) depending on several factors: size
of the treatment target (high risk area), anatomic structures that
could act as physical bounds to the movement, or candidate areas
to be protected (Fig. 4).
Simulation of final treatment parameters
The final step is the selection of the electron beam treatment
energy. Every time an energy value is selected, the corresponding
doseevolume histograms of all the regions of interest are plotted.
The user searches for the best possible coverage for the high risk
area combined with a clinically acceptable dose to organs and
normal tissues within the PTV. To improve the result, the previ
ously defined applicator parameters may be slightly modified.
Visual representation of isodose curves on two dimensional and
3D views over the treatment area and related tissues is also
valuable for this final step. The resulting values that maximize
treatment effectiveness can be stored in a single file. This feature
allows comparison of several simulations between users or even
alternative approaches from the same user (Fig. 5).
Possible uses
The system is meant to be used in the three phases of IOERT
procedure:3Preplanning
Several treatment or surgical alternatives can be assessed before
surgery. Because there is no time limit in this simulation, the RO
can improve the preparation for the real procedure.
Intraplanning
Treatment parameters can be updated from the preplanning
simulation during the IOERT procedure to assess the impact of the
intrasurgical modifications. Availability of intraoperative CT
would be best suited for this step.
Postplanning
Postsurgical control CT studies combined with the simulation tool
enable better patient follow up and also assessment of correlations
for late normal tissue toxicity and topographic characteristics of
cancer control or relapse.System evaluation in clinical cases by different
clinical users
The IOERT planning system was evaluated to determine whether
the proposed tools and workflow fulfill the needs of an RO when
preplanning these types of procedures. Three ROs took part in
this study: one of them (RO1) has had more than 20 years of
experience in IOERT working at HGUGM, and the other two
Fig. 2. Segmentation result for a patient with resectable pancreatic cancer. Healthy tissues have been contoured to potentially protect
them during intraoperative electron beam radiotherapy. Tumor and high risk area (tumor bed) are identified to guide applicator positioning.(RO2 and RO3) started the IOERT program in HPC 4 years ago.
This difference in clinical experience and site is expected to
provide clues about the ability of the system to account for the
needs of dissimilar user profiles. Less experienced users will be
confronted with cases that they have never seen in their clinical
practice, and their results will demonstrate the capability of the
Radiance system to improve their abilities in these situations.
Thirty six cases were retrieved at HGUGM over a 1 year period.
From this group, 15 cases were selected in such a way that the
most representative IOERT anatomic locations were included:
breast cancer (3 cases), rectal primary cancer (6 cases),Fig. 3. Surgical frame drawn on a patient with rectal monotopic recurr
of the frame.
4retroperitoneal sarcoma (1 case), resectable pancreatic cancer (1
case), rectal monotopic recurrence (2 cases), ovary monotopic
recurrence (1 case), and Ewing sarcoma (1 case). The described
method was completely independent of the standard clinical
treatment of the patients. In each of these 15 cases, every RO
performed the simulation process after accessing the patient’s
clinical history, including all relevant image studies, to prepare
for the procedure, although in our test setting there was no dia
logue with the surgeon responsible for every procedure. The
stepwise procedure for every patient followed the steps described
in the previous sections.ent cancer. Red and yellow lines indicate anterior and lateral limits
Fig. 4. Alternative applicator selection for the patient with rectal recurrent cancer shown in Fig. 3 (30 bevel angle in all cases). Top to
bottom: 70 cm, 80 cm, and 100 cm.After all ROs had performed the preplans on the 15 cases, the
resulting files were compared. Agreement between users was
evaluated for the following aspects: segmentation regions (quali
tatively), treatment parameters (considering agreement when
parameters were the same or within one step of difference) and
applicator position. The results for RO1 were used as a reference
because this user is the most experienced in IOERT. Applicator
position difference between two plans was calculated as the
Euclidian distance between the coordinate positions that corre
sponded to the center of the bevels. Perfect agreement was not
expected for all the cases. The aim of this study was to evaluate
the contribution of the Radiance treatment planning system to the
IOERT preplanning step, and also the confidence with which less
experienced users could approach new cases using such a system.
All users had the same treatment parameters available: bevel
angle (0, 30, and 45), diameter (3, 4, 5, 6, 7, 8, 9, 10, 12, and 15
cm) and energy (4, 6, 9, 12, 15, and 18 MeV). These possibilities
accounted for differences between plans, given that step difference
between possible parameter values is not constant.
Results
The results are presented grouped by their anatomic location. In
one rectal recurrence case, neither RO2 nor RO3 could define any
plan. In the remaining 14 cases, the values for applicator diameter5and energy never differed by more than one step, taking into
account the available steps defined at the end of the Methods
section. Treatment parameters are described in the Table.
Breast cancer
Segmented regions for breast cancer were always the tumor and
the risk area below it. The criteria followed to obtain those regions
were completely equivalent for the three ROs, with slight varia
tions in high risk area size. There was very high accordance in
treatment parameters, and applicator positioning differences were
below 1.2 cm for all cases.
Rectal cancer
According to the results of these cases, the segmentation limit for the
high risk area in rectal cancer was the mesorectal space, although
RO1 took into account the tumor location and involved nodes to
select a more restricted area. These differences led to applicator
position differences up to 3.3 cm in three cases (Rectal 1, 2, and 4).
In one case (Rectal 3) the procedure was similar for RO2 and RO3,
and RO1 planned a complex approach including two treatment
fields. Applicator positions for Rectal 5 and Rectal 6 were not
compared because the surgical access was anterior in the RO1 plan,
whereas RO2 and RO3 simulated a transperineal procedure.
Fig. 5. Breast cancer patient with alternative idealized simulations and their corresponding doseevolume histograms for heart, ribs, lung,
planning target volume, and tumor regions. Planning target volume corresponds to the post tumorectomy surgical bed. The first three rows
correspond to the same applicator and position but with increasing energies (6, 9, and 12 MeV) that modify dose contribution in tissues at
risk. The last row shows the effect of an incorrect positioning of the applicator.Retroperitoneal sarcoma
Retroperitoneal sarcomas are complex anatomic targets for the
postsurgical IOERT technique. However, the results in this case
show consistency in the definition of the tumor, risk area, and
treatment parameters. Applicator placement difference was less
than 1 cm.
Pancreatic cancer
Segmentation in this case was comparable for RO1 and RO2,
whereas RO3 contoured only the celiac trunk but not the tumor.
Because of this, the applicator position for RO3 was quite
different from that of RO1. RO1 was also less conservative in
terms of diameter and energy.6Rectal cancer monotopic recurrence
Plans were equivalent for the first case, although RO2 and RO3
segmented the tumor only, whereas RO1 included also a high risk
area, with complete accordance in the final position and treatment
parameters.
The second case could not be preplanned by either RO2 or
RO3 based on the clinical information provided. The case was
quite atypical, and they could not identify the risk area without
knowledge obtained during the actual surgical procedure.
Ovarian cancer monotopic recurrence
Segmentation, treatment parameters, and positions were all similar
in this case.
Table Results for the cohort of cases studied
Case description Radiation oncologist Energy (MeV) Diameter (cm)
Bevel angle
(degrees)
Applicator position
difference (cm)
Breast 1 1 6 7 0 d
2 6 7 0 0.379
3 6 7 0 1.193
Breast 2 1 6 7 0 d
2 6 5 0 0.532
3 4 6 0 0.324
Breast 3 1 6 6 0 d
2 6 6 0 0.704
3 6 6 0 0.625
Rectal 1 1 12 7 45 d
2 12 8 45 3.22
3 d d d d
Rectal 2 1 12 7 45 d
2 9 7 45 0.73
3 9 8 45 3.3
Rectal 3 1 d d d d
2 9 8 30 d
3 9 7 30 d
Rectal 4 1 12 7 30 d
2 9 8 45 2.64
3 9 8 45 1.06
Rectal 5 1 9 7 30 d
2 9 8 45 d
3 9 8 45 d
Rectal 6 1 12 8 45 d
2 12 7 45 d
3 12 7 45 d
Sarcoma 1 12 10 0 d
2 9 12 0 0.77
3 9 10 0 0.84
Pancreas 1 9 9 0 d
2 6 6 0 1.83
3 6 6 0 6.49
Rectal relapse 1 1 12 7 45 d
2 9 7 30 1.72
3 9 8 30 1.2
Ovarian relapse 1 9 7 30 d
2 9 7 45 0.58
3 9 7 30 0.68
Ewing sarcoma 1 12 9 0 d
2 9 10 30 4.13
3 9 10 30 3.46
RO1, RO2, and RO3 indicate single radiation oncologist results. The columns for every case show the treatment parameters selected by the user
(treatment energy, applicator diameter, and bevel angle). The last column depicts the applicator positioning error in millimeters using the RO1 position as
a reference when treatment plans were comparable.Ewing sarcoma
This was an extremely complex case because the access to the
posterior risk area location implied the need to approach the
patient with a certain body angulation during surgery. The tumor
segmentation was correct for the three users, but RO2 and RO3
were not able to identify the surgical requirements on patient
lateral positioning, and they performed the simulation with the
patient in a supine position and using anterior access. This was
why the treatment parameters and position were so different.7Discussion
Treatment planning is now a standard and necessary step in
external radiotherapy workflow. The use of image studies to
determine planning volume and organs at risk, together with
dose estimation algorithms, has improved the quality and accu
racy of these procedures. However, these contributions have not
yet been incorporated into IOERT because of the restrictions that
surgical conditions enforce. The treatment planning system
reported here overcomes part of these limitations, offering the
RO new capabilities: to evaluate different treatment approaches,
coordinate the decision process with the surgeons, prepare the
intervention, and consequently be more confident during the
final procedure. The evaluation has also demonstrated these
contributions in a representative set of clinical cases that have
been preplanned by expert and less experienced users. The
results obtained for every location will be very helpful in
defining new protocols on the use of this type of tool for IOERT
planning.
Breast cancer is a main indication for IOERT, inasmuch as
random studies (8, 9) are being carried out to demonstrate the
equivalence with external fractionated radiotherapy in breast
conserving surgery. Consequently, our results showing complete
equivalence between the planning parameters for all the users are
promising. Slight deviations in the size of the applicator in one of
the cases are fully consistent with differences in clinical practice
between institutions, and are always 1 cm up or down (8).
The results for the six cases of rectal cancer are more
heterogeneous, but they provide important details about the
possible role of the Radiance system in treating these cancer types
and locations. The decisions involved in the segmentation are
crucial for the rest of the planning procedure. The specific surgical
protocol followed in every institution is also responsible for
planning differences. The long experience in rectal cancer at
HGUGM (10, 11) allows for more sphincter preserving resections
and uses an anterior surgical approach, whereas the standard
procedure for RO2 and RO3 is perineal. Both protocols can be
carried out with the treatment planning system, although it seems
reasonable to look for consensus solutions when determining
planning volumes for irradiation. Regarding the treatment
parameters, all users selected energies of 9 or 12 MeV, diameters
of 7 or 8 cm, and a beveled applicator.
The remaining cases included various neoplastic entities and
anatomic locations (retroperitoneal sarcoma, pancreas, ovarian
and rectal relapse, and Ewing sarcoma). Despite the complexity of
these interventions (12e15), the results on most simulations were
similar. Considering the successful cases (three breast cancer,
three rectal cancer, retroperitoneal sarcoma, and rectal and ovarian
monotopic recurrences), the average applicator position difference
was 1.2  0.95 cm, with 82.3% of the cases below 2 cm. The
differences in energy and diameter were always within one step of
the possible values, and the choices for bevel angle diverged only
in some cases between 30 and 45. These plans can be considered
clinically equivalent.
In those cases where the approaches are dissimilar, the cause
has always been lack of information on how the surgical process
was actually performed. This finding encourages the need for
close collaboration between ROs and surgeons to obtain the
preplan that will be most adequate for guiding the real treatment.
The evaluation of these results suggests two main aspects to be
addressed to obtain comparable plans: correct identification of
high risk areas and knowledge of the modifications that related
structures will experience during surgery. The alternative solutions
are always related to one of these factors.
Even though treatment planning systems are an essential part
of the external radiotherapy workflow, this possibility has not been
available in IOERT until now. The lack of such tools has limited
the spread and acceptance of this technique (16, 17). Our work
contributes to the solution of simulation and preplanning needs,
demonstrating the system in several real clinical cases with
encouraging results. The ongoing clinical testing will continue
collecting users’ experience, which will allow adapting and8improving the system capabilities. The introduction of the pre
planning phase in IOERT guarantees documentation of the
procedure and facilitates quality assurance (18). It may also
support the main factors limiting the adoption of this technique by
reducing the learning curve of the RO and improving communi
cation with the surgical team.
The main limitation of the study is the use of preoperative
images that do not represent the modification of patient’s anatomy
during surgery. The clinical user must apply expert knowledge to
evaluate the differences between preplanning and the real
procedure. This limitation will be solved with the inclusion of
two features that are currently research projects under develop
ment: intraoperative imaging and advanced dose modeling.
Besides the advantages offered by these contributions, the current
system already fulfills several of the IOERT needs that had been
identified in previous literature reports and institutional expert
practice (1).
The Radiance treatment planning system offers a multidisci
plinary and user friendly environment to define and test the
IOERT parameters. It allows comparing several approximations
with the clinical case, facilitating the selection of the best
treatment parameters. This feature is a new contribution that has
not been available before. The cases presented here, simulated by
different ROs, have shown the ability of the system to solve
users’ requirements in different clinical scenarios. The stability
of the current development has allowed the installation and
evaluation of Radiance systems in four hospitals in Spain
(HGUGM, Clı´nica La Luz, HPC, Hospital Ramo´n y Cajal).
These centers are now collaborating in the establishment of new
protocols for IOERT that involve simulation and planning with
the presented tool.References
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